View in EDS

Membrane particles evoke a serotype-independent cross-protection against pneumococcal infection that is dependent on the conserved lipoproteins MalX and PrsA.

Saved in:
Bibliographic Details
Title: Membrane particles evoke a serotype-independent cross-protection against pneumococcal infection that is dependent on the conserved lipoproteins MalX and PrsA.
Authors: Narciso AR; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 65, Stockholm, Sweden.; Clinical Microbiology, Karolinska University Hospital, SE-171 76, Stockholm, Sweden., Iovino F; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 65, Stockholm, Sweden.; Clinical Microbiology, Karolinska University Hospital, SE-171 76, Stockholm, Sweden., Thorsdottir S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 65, Stockholm, Sweden.; Clinical Microbiology, Karolinska University Hospital, SE-171 76, Stockholm, Sweden., Mellroth P; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 65, Stockholm, Sweden.; Clinical Microbiology, Karolinska University Hospital, SE-171 76, Stockholm, Sweden., Codemo M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 65, Stockholm, Sweden.; Clinical Microbiology, Karolinska University Hospital, SE-171 76, Stockholm, Sweden., Spoerry C; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 65, Stockholm, Sweden.; Clinical Microbiology, Karolinska University Hospital, SE-171 76, Stockholm, Sweden., Righetti F; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 65, Stockholm, Sweden.; Clinical Microbiology, Karolinska University Hospital, SE-171 76, Stockholm, Sweden., Muschiol S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 65, Stockholm, Sweden.; Clinical Microbiology, Karolinska University Hospital, SE-171 76, Stockholm, Sweden., Normark S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 65, Stockholm, Sweden.; Clinical Microbiology, Karolinska University Hospital, SE-171 76, Stockholm, Sweden., Nannapaneni P; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 65, Stockholm, Sweden.; Clinical Microbiology, Karolinska University Hospital, SE-171 76, Stockholm, Sweden., Henriques-Normark B; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, SE-171 65, Stockholm, Sweden.; Clinical Microbiology, Karolinska University Hospital, SE-171 76, Stockholm, Sweden.
Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Jun 07; Vol. 119 (23), pp. e2122386119. Date of Electronic Publication: 2022 Jun 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1091-6490
DOI:10.1073/pnas.2122386119